Mayo Clinic Cardiovascular CME

Does Lifestyle Affect Pregnancy and Congenital Birth Defects?   Guest: Katie Young, M.D. Guest: Carl Rose, M.D. Host: Marysia Tweet, M.D., M.S.   Lifestyle choices before and during pregnancy can shape both maternal cardiovascular risk and fetal development. In this podcast, we explore how lifestyle factors before and during pregnancy influence maternal cardiovascular health and pregnancy outcomes.   Topics Discussed: If a woman wishes to become pregnant, what can she do to minimize risk of adverse events during pregnancy or the postpartum period?  Are there certain lifestyle choices that are known to cause pregnancy complications?  Are there certain lifestyle choices that are known to cause congenital birth defects?  Are there any women for whom you would advise daily baby aspirin during pregnancy?  Are there lifestyle factors that should prompt enhanced fetal cardiac surveillance? What cardiovascular or metabolic risk factors should ideally be optimized before conception? Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App: The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode.   Podcast episode transcript found here.

Gene Therapy and Genetic Cardiomyopathies   Guest: John Giudicessi, M.D., Ph.D. Host: Malcolm Bell, M.D.   In this podcast, listeners will learn what gene therapy is and the types of genes therapies under development for an array of genetically mediated cardiovascular disorders. In addition, active and upcoming gene therapy clinical trials for the treatment of specific arrhythmogenic, dilated, hypertrophic and restrictive cardiomyopathy genotypes will be discussed.   Topics Discussed: What is gene therapy? How do gene therapies differ from conventional management of genetic arrhythmogenic, dilated, hypertrophic and restrictive cardiomyopathies? Are there different types of gene therapies? What gene therapy trials are currently active or upcoming at Mayo Clinic and other institutions?   Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App: The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode.   Podcast episode transcript found here.   Recorded 21-October-2025

Leadless Pacemakers and Extravascular ICDs   Guest: Alan M. Sugrue, M.B., B.Ch., B.A.O. Host: Sharonne Hayes, M.D.   This episode of “Interviews With the Experts” explores how leadless pacemakers and extravascular ICDs are redefining device therapy by minimizing lead- and pocket-related complications while expanding options for patients with complex anatomy or infection risk. Listeners will learn how these systems differ from traditional transvenous technologies, review key data on safety and efficacy, and understand which patient profiles are best suited for each approach.   Topics Discussed: How do leadless pacemakers differ from traditional transvenous systems in terms of technology, complication profile, and clinical outcomes? In which patient populations should leadless pacing be considered as a first-line option? What are the key design and functional differences between extravascular and subcutaneous ICDs? What advantages and limitations should clinicians understand when deciding between these two systems?   Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App: The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode.   Podcast episode transcript found here.   Recorded 21-October-2025

Translating the DGA Into Real-World Cardiometabolic Care   Guest: Stephen L. Kopecky, M.D. Host: Kyla M. Lara-Breitinger, M.D., M.H.S.   In this third episode roundtable, Dr. Lara Breitinger and Dr. Steve Kopecky examine what the DGAs get right—and where they fall short—for cardiovascular risk, from their emphasis on whole-food patterns to ongoing gaps around food processing, nutrient oversimplification, and sustainability messaging. They share how they translate the guidelines into real-world cardiometabolic care, including the evidence-based principles they use in clinic and when to individualize beyond national recommendations. Looking ahead, they explore the future of nutrition guidance—food as medicine, precision cardiometabolic care, and outcomes-driven recommendations—reminding listeners that the DGA is a starting point and to focus on "one bite at a time."   Topics Discussed: The mismatch between guidelines and patients What the DGA gets right—and wrong—for CV risk How you counsel patients today Where nutrition guidance needs to go next   Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App: The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode.   Podcast episode transcript found here.   Recorded on: 10-February-2026

Applications of the New DGA   Guest: Tara Schmidt, RDN, LD Host: Kyla Lara-Breitinger, M.D., M.H.S.   Every five years, new dietary guidelines for Americans are put out by the U.S. Department of Health and Human Services (HHS) and U.S. Department of Agriculture (USDA). The Dietary Guidelines for Americans, 2025-2030 (10th edition) was recently published in early 2026 and has sparked some controversy with not only its visual icon, but some of its emphases as well. In this second episode reviewing the new DGA, Dr. Kyla-Lara Breitinger and Tara Schmidt, RDN, LD review what the new guidelines advise and what may be confusing for consumers.     Topics Discussed: Do you want to share a bit of history around the DGAs? What recommendations from the new DGAs align with longstanding nutrition science? Are there elements of the new guidelines that raise any concern? What should be some key nutritional focuses for Americans, given what we know about their health status?   Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App: The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode.   Podcast episode transcript found here.   Recorded on: 05-February-2026

Dietary Guidelines of America: What Changed, What Didn’t, and Why it Matters   Guest: Dariush Mozaffarian, M.D., Dr.P.H. Host: Kyla Lara-Breitinger, M.D., M.H.S.   The release of the new Dietary Guidelines for Americans has sparked important conversations across medicine, public health, and clinical practice. In this three-episode Interview with the Experts mini-series, Mayo Clinic preventive cardiologist Dr. Kyla Lara-Breitinger brings clarity to what the guidelines mean for patients and clinicians alike—cutting through headlines, controversy, and confusion with evidence-based insights from national and Mayo Clinic experts. Together, we explore what’s new, what remains unchanged, where debate persists, and how these guidelines translate into real-world cardiometabolic care, with a strong emphasis on practical, patient-centered nutrition advice.   Topics Discussed: Why does the new DGA matter for cardiology? What’s new vs. recycled? Core controversies Clinical takeaways   Referenced article: Mozaffarian D. The 2025-2030 Dietary Guidelines for Americans. JAMA. Published online January 14, 2026. doi:10.1001/jama.2026.0283 The 2025-2030 Dietary Guidelines for Americans | Lifestyle Behaviors | JAMA | JAMA Network    Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App: The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode.   Podcast episode transcript found here.   Recorded on: 27-January-2026

Conduction System Pacing   Guest: Nicholas Tan, M.D., M.S. Host: Anthony Kashou, M.D.   In this episode of the “ECG Making Waves” segment of Mayo Clinic’s cardiovascular podcast series “Interviews with the Experts,” Dr. Nicholas Tan joins us to discuss conduction system pacing. The listener will hear about the basics and rationale of conduction system pacing, as well as clinical scenarios where it should be considered.   Topics Discussed: How does conduction system pacing (or CSP) differ from conventional means of pacing? In broad strokes, how is CSP performed? In what situations would you consider doing CSP? Are there any risks or uncertainties regarding CSP?   Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App: The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode.   Podcast episode transcript found here.   Recorded 09-December-2025

AI Detection of Cardiac Amyloidosis   Guest: Patricia Pellikka, M.D. Host: Malcolm Bell, M.D.   Dr. Patricia Pellikka dives into the AI model she helped build. Working with an AI echo company, Ultromics Ltd., her team built an AI echo model to detect cardiac amyloidosis. The model works from an apical 4 chamber videoclip and was approved by the FDA via the breakthrough pathway. They have validated it internationally in a population with 22% prevalence of cardiac amyloidosis and it had a sensitivity of 85%, specificity 93%, PPV 78%, NPV 96%, and AUC 0.93.  The performance of the model was consistent across cardiac amyloid types; among AL, wild type ATTR, and hereditary ATTR, the sensitivity was 84%, 85%, and 86%, respectively.  The performance of the model was also superior to previously validated scores which use clinical and echocardiographic variables for detecting cardiac amyloidosis. The results of the study were published online in the European Heart Journal in July.   Topics Discussed: You have built an AI echo model to detect cardiac amyloidosis.  How did you get into this? Tell us about the model that you built. How did you validate it? How does the model compare with other screening methods for detecting cardiac amyloidosis? What are the next steps for your research?   Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App: The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode.   Podcast episode transcript found here.

Clopidogrel Monotherapy in Chronic Coronary Artery Disease   Guest: Keri Zieminski, APRN, C.N.P., D.N.P. Host: Sharonne Hayes, M.D.   This episode of Mayo Clinic’s “Interviews With the Experts” will give an overview of clopidogrel monotherapy in patients with chronic CAD that are not on anticoagulation. Discussion will include why there has been a shift towards redefining antiplatelet medical therapy for this patient population, brief overview of recent trials, and how to manage a patient on clopidogrel monotherapy that needs to undergo noncardiac surgery.   Topics Discussed: Why has there been a shift towards redefining antiplatelet medical therapy in patients with chronic CAD? What's changed? Recently published trials that highlight clopidogrel monotherapy. What is your process for managing a patient on clopidogrel monotherapy that needs to go for noncardiac surgery?   Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App: The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode.   Podcast episode transcript found here.

Global Practices in Cardiac Imaging for Cardiac Sarcoidosis   Guest: Tahir Kafil, M.D. Host: Sharonne Hayes, M.D.   Cardiac imaging is a cornerstone in the diagnostic work-up and management of cardiac sarcoidosis. However, indications and use of advanced cardiac imaging vary from institution to institution, and even between providers at the same institution. We conducted an international Delphi consensus study of 89 global experts in cardiac sarcoidosis to evaluate real-world clinical practices and use of advanced cardiac imaging. We developed consensus for use of advanced cardiac imaging in cardiac sarcoidosis. Areas lacking consensus were noted as priority areas for research.   Topics Discussed: From a big picture perspective, how is cardiac sarcoidosis generally diagnosed? What exactly is the Delphi methodology your team used to build consensus?  The suggested algorithm for imaging in suspected cardiac sarcoidosis uses pretest probability, how was that defined? Was cardiac MRI superior to PET in your study? Does one have to be first? How do experts decide how often to do follow up PET imaging in established cardiac sarcoidosis? What were areas of priority research that were identified? The research study cited by Dr. Kafil was published on June 2, 2025. Click the following link to view the paper: https://www.jacc.org/doi/full/10.1016/j.jcmg.2025.02.010   Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App: The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode.   Podcast episode transcript found here.

Anticoagulation Monotherapy in Patients with Chronic Coronary Artery Disease and Atrial Fibrillation   Guest: Keri Zieminski, APRN, C.N.P., D.N.P. Host: Sharonne Hayes, M.D.   This episode of Mayo Clinic’s “Interviews With the Experts” will give an overview of anticoagulation monotherapy in patients with chronic CAD and atrial fibrillation. Discussion will include a brief overview of recently published trials that highlight the use of anticoagulation monotherapy in chronic CAD with atrial fibrillation, and how to manage a patient on anticoagulation monotherapy that needs to undergo noncardiac surgery.    Topics Discussed: Why has there been a shift towards redefining antithrombotic medical therapy in patients with chronic CAD with atrial fibrillation? What's changed? Recently published trials that highlight the use of anticoagulation monotherapy in the chronic CAD + AF population. What is your process for managing a patient on anticoagulation monotherapy that needs to go for noncardiac surgery?    Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App: The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode.   Podcast episode transcript found here.

Updated Guidelines for Perioperative Cardiovascular Management for Noncardiac Surgery   Guest: Michael Cullen, M.D. Host: Kyle Klarich, M.D.   This episode of Mayo Clinic’s “Interviews With the Experts” reviews the assessment of patients with known or suspected cardiovascular disease undergoing noncardiac surgery.  Dr. Michael Cullen discusses recommendations from 2024 ACC/AHA perioperative guidelines regarding medication management before and after noncardiac surgery, including recommendations for antiplatelet therapy and bridging anticoagulation.  Finally, he highlights new recommendations in the recent 2024 ACC/AHA perioperative guidelines and compare these guidelines to the 2022 European Society of Cardiology perioperative guidelines.   Topics Discussed: How should clinicians approach the assessment of a patient prior to noncardiac surgery? How should physicians and APPs manage cardiac medications around the time of noncardiac surgery? What are some of the new recommendations in the 2024 ACC/AHA guidelines for perioperative management prior to noncardiac surgery? How do the 2024 ACC/AHA perioperative guidelines differ from the 2022 ESC noncardiac surgery guidelines?   Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App: The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode.   Podcast episode transcript found here.

Obesity, Hypertension, and Risk Factors in Terms of Prevention and Decreasing the Risk of HfpEF   Guest: Affan Irfan, M.D., Ph.D. Host: Stephen L. Kopecky, M.D.   HFpEF is a type of heart failure where the heart pumps normally but becomes stiff. This leads to fatigue, shortness of breath, and fluid retention. It is closely linked to obesity, hypertension, and metabolic disorders, with cases rising as these conditions become more common.   Topics Discussed: What is HFpEF and its risk factors? How common are obesity and hypertension, and how often do they lead to HFpEF? How do you diagnose HFpEF? How effective are weight loss, diet, and exercise in preventing HFpEF? What medical and public health strategies help reduce these risk factors and HFpEF cases?    Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App: The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode.   Podcast episode transcript found here.

Aortic Regurgitation: Beyond the Valve   Guest: Vidhu Anand, M.B.B.S. Host: Kyle Klarich, M.D.   In this episode of Mayo Clinic’s “Interviews With the Experts,” Dr. Klarich and Dr. Anand discuss evolving approaches to assessing left ventricular remodeling in chronic aortic regurgitation. Dr. Vidhu Anand discusses research showing that LV volumes, global longitudinal strain, and myocardial fibrosis can detect dysfunction earlier than traditional guideline thresholds. Listeners can expect to better understand the role of multimodality imaging, extra valvular involvement, and practical steps echocardiographers can take to optimize AR assessment.    Topics Discussed: What imaging markers help detect early myocardial dysfunction in AR, and how do they assist in risk stratification? Guidelines traditionally focus on LV dimensions and ejection fraction for surgical decision-making in AR. Is there any data that guidelines may not be capturing patients at the optimal time? Is there a role of multimodality imaging in AR? What practical steps can a sonographer or echocardiographer today to bring their AR assessment closer to what your research suggests is optimal?     Please reference Dr. Anand's research article(s) here: https://pubmed.ncbi.nlm.nih.gov/39545891/ https://pubmed.ncbi.nlm.nih.gov/33253815/ https://pubmed.ncbi.nlm.nih.gov/39218370/   Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App: The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode.   Podcast episode transcript found here.

Presentation, Evaluation, and Management of Premature Ventricular Contractions   Guest: Alan M. Sugrue, M.B., B.Ch., B.A.O. Host: Anthony H. Kashou, M.D.   In this episode, Dr. Anthony Kashou and Dr. Alan Sugrue cover a practical, evidence-based approach to premature ventricular contractions (PVCs), from incidental findings to high-burden, high-risk presentations. Listeners will gain tools to differentiate benign from pathologic PVCs, understand when to monitor versus refer, and recognize the role of catheter ablation in improving outcomes.   Topics Discussed: PVCs show up on Holters and ECGs all the time — how do you decide when they matter? How often do PVCs cause cardiomyopathy, and when should we act? When should we consider ablation even if the patient is asymptomatic? What’s the biggest misconception about PVC ablation today? Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App: The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode. Podcast episode transcript found here.

Tricuspid Regurgitation: New Insights and Implications for Clinical Practice   Guest: Vidhu Anand, M.B.B.S. Host: Kyle Klarich, M.D.   This episode of Mayo Clinic’s “Interviews With the Experts,” explores new insights into tricuspid regurgitation and its implications for clinical practice. Dr. Vidhu Anand discusses the dynamic nature of TR, its impact on prognosis, and the importance of close monitoring even when the condition appears to improve. The conversation highlights evolving guideline considerations, patient risk stratification, and how AI and machine learning may soon support earlier, more personalized interventions. Listeners will gain practical takeaways on when to escalate care and how to optimize long-term outcomes for TR patients.   Topics Discussed: How has our understanding of the natural history of tricuspid regurgitation changed, and what does this mean for the way we monitor and counsel patients? What are the current indications for intervention in isolated TR? How is TR currently classified? Are there any novel classifications based on patient’s risk profile, since comorbidities play an important role in TR? Review of Mayo Clinic study using AI/machine learning and outcomes in TR.   Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App: The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode.   Podcast episode transcript found here.

Cardiovascular Diet Myths   Guest: Stephen Kopecky, M.D. Host: Sharonne Hayes, M.D.   Since 2018, Trans-Fats are prohibited from being a food additive in the US. In this episode of “Interviews With the Experts,” Dr. Stephen Kopecky discussed how trans fats are still in our food, just not as much as pre-2018, and the main sources of trans fat are ultra-processed foods. Listeners will learn what foods scan raise your blood cholesterol (LDL-C) levels, increase heart attack risk, accelerate the aging process, and slow the aging process.   Topics Discussed: Are some trans-fats still sneaking into our food? If a person eats food high in cholesterol, can blood levels of cholesterol (LDL-C) go up? Which artificial sweeteners increase CV risk? Can diet actually speed up or slow down the aging process?    Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App: The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode.   Podcast episode transcript found here.

Evolving Treatment Landscape in Transthyretin Cardiac Amyloidosis   Guest: Rosalyn Adigun, M.D., Pharm.D. Host: S. Allen Luis, M.B.B.S., Ph.D.   In this episode of Mayo Clinic’s “Interviews With the Experts,” Dr. Allen Luis interviews Dr. Rosalyn Adigun on transthyretin cardiac amyloidosis. Listeners will come away with a detailed overview of the evolution of treatment options for patient diagnosed with transthyretin amyloid cardiomyopathy, highlighting historical perspectives, early registration studies, current treatment options, and an outlook on future directions in the management of transthyretin cardiac amyloidosis.   Topics Discussed: Overview of the historical perspectives on the diagnosis and management of transthyretin amyloidosis. Current treatment options available for transthyretin amyloid cardiomyopathy, and factors that should guide a clinician's decision regarding the choice of therapy. Treatment options in the coming years. Ongoing research initiatives in the management of cardiac amyloidosis.    Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App: The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode.   Podcast episode transcript found here.

Radiation Therapy and its Effect on the Heart and Cardiac Devices   Guest: Nicholas Tan, M.D., M.S. Host: Anthony H. Kashou, M.D.   Mayo Clinic electrophysiologist Dr. Nicholas Tan joins Dr. Anthony Kashou on this episode of “ECG Making Waves” to discuss how radiation therapy can impact the heart and heart rhythm. After listening to this podcast, listeners will have developed awareness of the complexities behind managing cardiac devices in cancer patients.   Topics Discussed: What effect does radiation therapy have on the heart? What arrhythmias can be seen with radiation therapy? How can radiation therapy impact cardiac device management? Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App: The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode. Podcast episode transcript found here.

When to Consider Intervention for Peripheral Arterial Disease   Guest: Stan Henkin, M.D. Host: Malcolm Bell, M.D.   Although optimal medical therapy is key to decrease the risk of major adverse cardiac events in patients with peripheral artery disease (PAD), lower extremity arterial revascularization also plays an important role in management of symptoms and prevention of amputation. Thus, it is important to recognize the optimal timing for patient to be referred for lower extremity arterial revascularization. This podcast will discuss when patients with established PAD should be considered for peripheral revascularization.   Topics Discussed: Can you tell us about clinical subsets of PAD and what symptoms may be expected with each subset? Recent BEST-CLI trial garnered a lot of attention and press. Can you tell us more about this trial and why results are important for treatment of patients with CLTI? When should a patient with claudication be referred for revascularization?    Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App: The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode.   Podcast episode transcript found here.